Insiders Trading CLVS, SJM, SYK

By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading.

NEW YORK ( TheStreet) -- Which insiders are selling and buying chunks of stocks?

Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission on Tuesday, April 10, 2012 as ranked by dollar value. Company executives and directors are in the best position to assess the attractiveness of their firms' shares, and here is how many of them are voting their wallets! Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction.

Clovis Oncology (CLVS) McKinley Edward J DIR 25,000 $500,000
Opko Health (OPK) Frost Phillip Md CEO,CB
DIR,BO
50,000 $231,832
Saga Communications (SGA) Towerview BO 2,631 $91,791
Angiodynamics (ANGO) Devivo Joseph PR,CEO
DIR
5,000 $59,094
Qualstar Corp (QBAK) BKF Capital Group BO 23,400 $45,148
Keryx Biopharmaceuticals (KERX) Feczko Joseph M DIR 20,000 $32,400
Aehr Test Systems (AEHR) Erickson Gayn PR,CEO
DIR
20,000 $21,341
Angiodynamics (ANGO) Kapusta Matthew C VP,BD 1,000 $11,397
Sed International Holdings (SED) Kidston Samuel A DIR 2,858 $10,975
Thunder Mountain Gold (THMG) Chapman Robert Llee DIR 100,000 $10,000
Source: www.InsiderInsights.com
Google (GOOG) Page Lawrence CEO,DIR
BO
27,778 $17,493,424
Smucker JM (SJM) Smucker Mark T PR,DIR 20,000 $1,612,000
Stryker (SYK) Stryker Ronda E DIR 18,000 $968,261
Houston American Energy (HUSA) Tawes Orrie Lee DIR,BO 231,800 $947,174
Grand Canyon Education (LOPE) Richardson Brent D CB,DIR 34,300 $562,322
Advanced Energy (AEIS) Schatz Douglas S DIR 41,738 $502,523
Express (EXPR) Moellering Matthew C VP,COO 19,500 $472,680
Iridium Communications (IRDM) Greenhill BO 55,000 $460,591
Solazyme (SZYM) Wolfson Jonathan S CEO,DIR 32,500 $450,964
Bridgepoint Education (BPI) McAuliffe Jane VP 20,000 $409,704
Source: www.InsiderInsights.com

Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, EVP=Executive Vice President, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.
Jonathan Moreland is the founder of InsiderInsights.com, which produces a weekly newsletter and offers professional screening and alerting tools to analyze a proprietary, real-time insider data feed. He is also the principal of Insider Asset Management, a registered investment advisor in New York. Mr. Moreland has been analyzing insider data professionally for two decades and has been a contributor to TheStreet.com since 2001. A fundamental analyst with an MBA in finance, Mr. Moreland long ago identified insider data as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

If you liked this article you might like

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

One of Wall Street's Hottest Biotech Stocks Tanks, Is Now the Time to Pounce?

Clovis Sell-Off May Be Overdone

Discovery, Clovis, Hertz Are Monday's Worst Performing Stocks -- Here's Why